Further study on the molecular mechanisms of CX3CL1/CX3CR1 axis in regulating microglial activation might provide useful information to determine the value of CX3CL1/CX3CR1 axis as a target for ALS therapy. Here, CX3CR1 is linked to amyotrophic lateral sclerosis.